President and Chief Executive Officer Jim Clemmer joined AngioDynamics in April 2016, bringing more than 25 years of leadership within the healthcare industry and a proven track record of success.
Prior to AngioDynamics, Clemmer served as president of the $1.8 billion medical supplies segment at Covidien plc., where he directed strategic and day-to-day operations for global business divisions that collectively manufactured 23 different product categories. In addition, he managed global manufacturing, research and development, operational excellence, business development and all other functions associated with the medical supplies business. Prior to his role at Covidien, Clemmer served as group president at Kendall Healthcare, where he managed the US business across five divisions and built the strategic plan for the Medical Supplies segment before it was spun off from Tyco. Clemmer began his career at Sage Products, Inc.
Clemmer currently serves on the Board of Directors for AngioDynamics and Lantheus Medical Imaging. Clemmer is a graduate of the Massachusetts College of Liberal Arts.
Executive Vice President and Chief Financial Officer Michael C. Greiner joined AngioDynamics in August 2016, bringing more than 20 years of experience in accounting, corporate finance and operations.
Prior to AngioDynamics, Greiner served as the Chief Financial Officer at Extreme Reach, Inc., a cloud-based enterprise platform for brand advertising, responsible for all finance and human resource operations. Prior to his role at Extreme Reach, Greiner held several executive roles, including Senior Vice President Corporate Finance and Chief Accounting Officer at Cimpress N.V. (formerly known as Vistaprint N.V.), Global Controller for GE’s Water and Processing Technologies division and leadership roles at Bausch & Lomb and Wyeth.
Greiner has also served as an adjunct professor at several universities and earned a Master’s in Business Administration from Columbia University Business School, as well as a Bachelor and Master of Science in Accounting from Fairleigh Dickinson University. Greiner is a certified public accountant and an advisor for Mirah, Inc., a mental healthcare technology start-up. Greiner also currently serves as the President of the Foundation for Faces of Children.
Senior Vice President and General Counsel Stephen A. Trowbridge joined AngioDynamics in June 2008 as corporate counsel. Mr. Trowbridge manages AngioDynamics’ legal matters, including corporate governance, mergers and acquisitions, finance, securities regulation, litigation, regulatory matters, intellectual property and compliance. Mr. Trowbridge also oversees the Company’s clinical affairs, medical affairs and healthcare economics departments. Prior to AngioDynamics, Mr. Trowbridge served as Corporate Counsel at Philips Healthcare and Intermagnetics General Corporation. Mr. Trowbridge began his career with Cadwalader, Wickersham & Taft LLP in the firm’s Mergers and Acquisitions and Securities Group. Mr. Trowbridge received a Bachelor of Science in Science and Technology Studies from Rensselaer Polytechnic Institute, a Juris Doctor from the University of Pennsylvania Law School, and a Master of Business Administration from Duke University’s Fuqua School of Business.
Senior Vice President and General Manager for Vascular Interventions and Therapies Robert A. Simpson joined AngioDynamics in February 2017. Prior to AngioDynamics, Mr. Simpson served as the Vice President and General Manager of the Patient Care Global Business at Medtronic. He was responsible for leading the business strategy and operations while ensuring global execution. Prior to his role within the Patient Care business, Mr. Simpson led strategy and business development for Medtronic’s Patient Monitoring & Recovery business. Mr. Simpson also held various leadership roles in Sales and Marketing during his time at Covidien (Medtronic) and Alcon (Novartis). Mr. Simpson received a Bachelor of Science in Management Science - Finance from the State University of New York at Geneseo and has completed a comprehensive, executive leadership development program at Babson College.
Senior Vice President and General Manager, Vascular Access, Chad Campbell joined the AngioDynamics team in May 2016 bringing more than 20 years of sales and marketing experience. Mr. Campbell joined AngioDynamics from Medtronic where he served as the Vice President of Marketing for the Patient Care and Safety business after serving as the Vice President of Marketing for the SharpSafety business at Covidien. During his tenure at Covidien, Campbell also held roles as Director of Marketing, Area Vice President of Sales, Region Manager, Product Manager and Account Manager. Mr. Campbell holds a Bachelor of Arts degree from the University of Kentucky.
Senior Vice President and General Manager of Oncology Brent J. Boucher joined AngioDynamics in November 2017. Prior to joining AngioDynamics, Mr. Boucher served as Executive in Residence for PDI's Infection Prevention business. Prior to that, he spent 20 years at Covidien where he served as General Manager for several global businesses, including Lung Solutions, Surgical Solutions and Respiratory Care. Mr. Boucher is a graduate of North Dakota State University.
Senior Vice President of Global Operations and R&D, David D. Helsel joined AngioDynamics in December 2017. Prior to joining AngioDynamics he was Senior Vice President, Global Supply Chain, at Hill-Rom Holdings for almost three years. Before that, Mr. Helsel worked at Haemontiecs for three years where he served as Executive Vice President for Global Manufacturing and also spent almost nineteen years in various positions with increasing responsibility at Covidien, including Vice President of Operations for the Surgical Solutions Division and Medical Supplies Division. An expert in Lean and Six Sigma, Mr. Helsel also served as Global Director of Operational Excellence, supporting sixty-three manufacturing facilities. Mr. Helsel holds a Bachelor of Science in Mechanical Engineering from LeTourneau University.